PINXY yields 3.45% · JNJ yields 2.13%● Live data
📍 PINXY pulled ahead of the other in Year 1
Combined, PINXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PINXY + JNJ for your $10,000?
The People's Insurance Company (Group) of China Limited, an investment holding company, engages in the insurance business in the People's Republic of China. It operates through Non-Life Insurance, Life Insurance, Health Insurance, Asset Management, and Others segments. The company offers property and casualty insurance products, including motor vehicle, commercial property, liability, credit, accidental injury and health, cargo, agricultural, and other insurance products. It also provides life insurance products comprising general life and health insurance, participating life insurance, universal life insurance, and accident insurance; and health insurance products, such as medical, illness, nursing care, accidental injury, disability losses, and participating endowment insurance products. In addition, the company engages in asset management, insurance agent, and reinsurance business, as well as offers integrated financial products and services. The People's Insurance Company (Group) of China Limited was founded in 1949 and is based in Beijing, the People's Republic of China.
Full PINXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.